Icon (NASDAQ:ICLR) will be posting its quarterly earnings results after the market closes on Wednesday, July 24th. Analysts expect Icon to post earnings of $1.68 per share for the quarter. Icon has set its FY19 guidance at $6.75-6.95 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Icon (NASDAQ:ICLR) last released its earnings results on Wednesday, May 1st. The medical research company reported $1.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.03. The firm had revenue of $674.85 million for the quarter, compared to analyst estimates of $668.93 million. Icon had a return on equity of 25.71% and a net margin of 12.56%. Icon’s revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.44 earnings per share. On average, analysts expect Icon to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
NASDAQ:ICLR opened at $153.67 on Tuesday. The business’s 50-day moving average price is $148.90. The firm has a market capitalization of $8.24 billion, a price-to-earnings ratio of 24.43, a P/E/G ratio of 2.10 and a beta of 0.56. Icon has a 52-week low of $118.10 and a 52-week high of $156.34. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.30.
Icon Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
See Also: What are earnings reports?
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.